机译:胃泌素抑制涉及EGR1,AE2和P-ERK的新型病理性结肠癌信号通路
Department of Pathology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Institutes of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People’s Republic of China;
Department of Pathology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Institutes of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People’s Republic of China;
Department of Pathology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Institutes of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People’s Republic of China;
Renal Division and Molecular and Vascular Medicine Unit, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA;
Department of Pharmacy, Shanghai Jiao;
Anion exchanger 2; Tumor suppressor P16; ERK; Gastrin;
机译:胃泌素抑制涉及EGR1,AE2和P-ERK的新型病理性结肠癌信号通路
机译:Genipin诱导细胞凋亡通过Egr1 / p21信号通路抑制AGS人胃癌细胞的细胞增殖
机译:“丹申改善了结肠癌和二羟基异甘油的患者存活的勘探,I通过细胞凋亡和SKP2信号通路抑制结肠癌细胞的增殖”[J。 ethnopharmacol。 209(2017)305-316]
机译:人结肠癌通过非CCK_1,非CCK_2受体识别N-羧甲基胃泌素
机译:马齿ula提取物可通过调节Notch信号转导通路的基因表达抑制结肠癌干细胞的结节形成
机译:胃泌素抑制了涉及EGR1AE2和P-ERK的新型病理结肠癌信号通路
机译:胃泌素抑制一种新的病理结肠癌信号通路,涉及EGR1,AE2和P-ERK